No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ALGN Align Technology
- 261.120
- -2.900-1.10%
Close May 22 16:00 ET
- 264.860
- +3.740+1.43%
Post 19:26 ET
19.66BMarket Cap43.09P/E (TTM)
264.680High260.220Low461.08KVolume264.010Open264.020Pre Close120.90MTurnover0.66%Turnover Ratio44.94P/E (Static)75.28MShares413.20052wk High5.23P/B18.33BFloat Cap176.34052wk Low--Dividend TTM70.21MShs Float737.452Historical High--Div YieldTTM1.69%Amplitude1.260Historical Low262.216Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Align Technology Appoints Emory Wright, Evp Direct Fabrication Manufacturing Platform to Build the Company’s Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026
AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval
Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--May 22, 2024-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign sys
Down -9.19% in 4 Weeks, Here's Why You Should You Buy the Dip in Align Technology (ALGN)
Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
Comments
Recent insider share sale at around US$300 raises caution. Despite some insider buying, the long-term outlook isn't positive. However, significant insider ownership suggests management's incentives align with shareholders.
Don't Ignore The Insider Selling In Align TechnologyAlign Technology's falling ROCE trend is concerning. The stock's modest 18% gain over five years may reflect investor caution. Those seeking a multi-bagger might find better opportunities elsewhere.
The company's positive sales forecast, spurred by increased revenue from its Invisalign teeth-alignment system, resulted in a 10.3% surge in after-hours shares. This follows last year's demand concerns due to fewer dental visits and higher prices for essentials. The shutdown of competitor SmileDirectClub last month may have also boosted the optimistic outlook.
$Align Technology(ALGN.US$ seems weak today
Investors are ready to pay more for Align Technology's shares, anticipating future growth. The high P/E ratio reflects positive investor sentiment, while a share price drop seems unlikely in the current circumstances.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg